🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 648.57 -1.7% NASDAQ 100: 582.06 -1.9% Dow Jones: 455.89 -1.1%

Joel Greenblatt’s AZN Holdings & Trades

First Buy
Q1 2014
Duration Held
4 Quarters
Largest Add
Q1 2014
+95,518 Shares
Current Position
2,084 Shares
$383,256 Value

Joel Greenblatt's AZN Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 2,084 shares of AstraZeneca PLC (AZN) worth $383,256, representing 0.00% of the portfolio. First purchased in 2014-Q1, this short-term holding has been held for 4 quarters.

Based on 13F filings, Joel Greenblatt has maintained this position in AZN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1,368 shares. Largest reduction occurred in Q2 2014, reducing 95,518 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's AstraZeneca PLC (AZN) Holding Value Over Time

Track share changes against reported price movement

Quarterly AstraZeneca PLC (AZN) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +716 Add 52.34% 2,084 $183.90
Q3 2025 +1,368 New Buy 1,368 $153.50
Q2 2014 -95,518 Sold Out 0 $0.00
Q1 2014 +95,518 New Buy 95,518 $64.88

Joel Greenblatt's AstraZeneca PLC Investment FAQs

Joel Greenblatt first purchased AstraZeneca PLC (AZN) in Q1 2014, acquiring 95,518 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held AstraZeneca PLC (AZN) for 4 quarters since Q1 2014.

Joel Greenblatt's largest addition to AstraZeneca PLC (AZN) was in Q1 2014, adding 95,518 shares worth $6.2 M.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 2,084 shares of AstraZeneca PLC (AZN), valued at approximately $383,256.

As of the Q4 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in AstraZeneca PLC (AZN) was 95,518 shares, as reported at the end of Q1 2014.